SARS-CoV-2 seroprevalence, seroconversion and neutralizing antibodies in a systemic lupus erythematosus cohort and comparison to controls.
Hannah R MathewMay Y ChoiKatherine BuhlerXenia GukovaFrancesca S CardwellHeather WaldhauserAnn E ClarkeMarvin J FritzlerPublished in: Lupus (2021)